-
-
-
-
-
-
-
Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers
-
-
-
-
-
-
-
Gilead quarterly revenue drops 4%, oral COVID drug fails trial
-
-
-
-
-
-
-
Midday movers: Small cap stocks rule, Archer-Daniels-Midland falls, and more
-
-
-
-
-
-
-
Gilead Sciences (GILD) Tops Q3 EPS by 38c, Offers Guidance
-
-
-
-
-
-
-
Gilead Sciences (GILD) and Assembly Biosciences (ASMB) Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases
-
-
-
-
-
-
-
Gilead Sciences Announces Second Quarter 2023 Financial Results
-
-
-
-
-
-
-
Gilead profit misses Wall Street expectations as COVID drug sales decline
-
973,636 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All